Therefore, the identification of C/EBPα-DDIT3 axis as a regulator of UPR signaling during myeloid differentiation helps us better understand the physiological mechanisms by which HSPCs with CEBPA deficiency avoid leukemia transformation. The gene discussed is DDIT3; the disease is leukemia.